| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 01/26/2010 | US7652020 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 01/21/2010 | WO2010009405A2 Targeted nitroxide agents |
| 01/21/2010 | WO2010008490A1 The use of 2-hydroxy-5-oxoproline in conjunction with algae |
| 01/21/2010 | WO2010007626A1 A method of synthesizing a substantially monodispersed mixture of oligomers |
| 01/21/2010 | WO2010007248A2 Novel tricyclic derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 01/21/2010 | WO2010007027A1 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors |
| 01/21/2010 | WO2010006725A1 Insecticidal compounds |
| 01/21/2010 | US20100016578 Macrocyclic serine protease inhibitors |
| 01/21/2010 | US20100016550 Methods for Site-Specific Pegylation |
| 01/21/2010 | US20100016397 Pyrrole and Pyrazole DAAO Inhibitors |
| 01/21/2010 | US20100016383 4-(3,3-dihalo-allyloxy)phenol derivatives having pesticidal properties |
| 01/21/2010 | US20100016375 1,5-diphenyl-3-pyridinylamino-1,5-dihydropyrrolidin-2-one as cb1 receptor modulator |
| 01/21/2010 | US20100016374 Compounds Which Inhibit the Glycine Transporter and Uses Thereof |
| 01/21/2010 | US20100016295 Preparation and Use of Biphenyl Amino Acid Derivatives for the Treatment of Obesity |
| 01/21/2010 | US20100016286 Anti-Inflammatory Agents |
| 01/21/2010 | US20100015136 Camptothecin-peptide conjugates and pharmaceutical compositions containing the same |
| 01/21/2010 | US20100015130 Disc-1 pathway activators in the control of neurogenesis |
| 01/21/2010 | US20100015076 Polymer structure reacting with keratin, synthesis and use thereof |
| 01/21/2010 | CA2730708A1 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors |
| 01/21/2010 | CA2730516A1 Novel tricyclic derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 01/20/2010 | EP1831159B1 Tetralin and indane derivatives and uses thereof |
| 01/20/2010 | EP1824819B1 Pyrrolidin-2-one derivatives for use as dp1 receptor agonists |
| 01/20/2010 | EP1805141B1 Piperidines and related compounds for treatment of alzheimer's disease |
| 01/20/2010 | EP1490333B1 New atorvastatin salts and pharmaceutical compositions containing them |
| 01/20/2010 | EP1458679B1 Pyrrolidine derivatives as prostaglandin modulators |
| 01/20/2010 | EP1202961B1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 01/19/2010 | US7649055 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support |
| 01/19/2010 | US7649011 Inhibitors of human tumor-expressed CCXCKR2 |
| 01/19/2010 | US7649001 Fused benzene derivative and use |
| 01/19/2010 | US7648738 for photopolymerization; photography, relief imaging; color filters |
| 01/19/2010 | CA2427660C Biphenylcarboxamides useful as lipid lowering agents |
| 01/19/2010 | CA2427177C Process for preparing distamycin derivatives |
| 01/19/2010 | CA2368097C Amide derivatives of 3,4-dihydroquinazolinone compounds useful as cytokine inhibitors |
| 01/19/2010 | CA2143135C Process for sulfinylating heterocyclic compounds |
| 01/14/2010 | WO2010005783A1 Pyrrolidinyl and piperidinyl compounds useful as nhe-1 inhibitors |
| 01/14/2010 | WO2010004972A1 Nitrogen-containing aromatic heterocyclyl compound |
| 01/14/2010 | WO2010003226A1 Chiral acyclic diaminocarbene ligands, precursors therefore and their use in organic synthesis reactions |
| 01/14/2010 | WO2009132453A8 Cyclylamine derivatives as calcium channel blockers |
| 01/14/2010 | US20100010235 Method of using rhodium quinonoid catalysts |
| 01/14/2010 | US20100010234 Process for manufacturing a glutamic acid derivative and a pyroglutamic acid derivative and a novel intermediate in the manufacture thereof |
| 01/14/2010 | US20100010222 Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising ep4 agonist as active ingredient |
| 01/14/2010 | US20100010216 2-fluorinated acyl-3-aminoacrylonitrile derivative and method for producing the same |
| 01/14/2010 | US20100010063 Heterocyclocarboxamide derivatives |
| 01/14/2010 | US20100010004 Inhibitors of histone deacetylase |
| 01/14/2010 | US20100009988 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 01/14/2010 | US20100009961 Dipeptidyl peptidase-iv inhibitors |
| 01/14/2010 | US20100009933 Hydroxylated amide skin moisturizer |
| 01/14/2010 | CA2730307A1 Chiral acyclic diaminocarbene ligands, precursors therefore and their use in organic synthesis reactions |
| 01/14/2010 | CA2730116A1 Pyrrolidinyl and piperidinyl compounds useful as nhe-1 inhibitors |
| 01/14/2010 | CA2730078A1 Nitrogen-containing aromatic heterocyclyl compound |
| 01/13/2010 | EP2143713A1 Novel pyrrolinone derivative and medicinal composition containing the same |
| 01/13/2010 | EP2143444A1 Compositions for inhibition of anglogenesis |
| 01/13/2010 | EP2143420A1 Formulation comprising mutant/s of lysosomal alpha-galactosidase A for the treatment of Fabry disease |
| 01/13/2010 | EP2142502A1 Pyrrole and isoindole carboxamide derivatives as p2x7 modulators |
| 01/13/2010 | EP2142499A1 Subsituted sulphonamides, process for their preparation, pharmaceutical composition comprising thereof and their use |
| 01/13/2010 | EP2021337B1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 01/13/2010 | EP1575911B1 Biaromatic compounds which activate ppar-gamma type receptors and use thereof in cosmetic or pharmaceutical compositions |
| 01/13/2010 | CN101624363A Processing method of bile by ultrasonic wave |
| 01/13/2010 | CN101624362A Method for preparing levetiracetam |
| 01/13/2010 | CN100579962C Aryl pyrrole compounds with insecticidal, miticidal and fungicidal bioactivities and process for preparing same |
| 01/13/2010 | CN100579957C Novel arylamidine derivative or salt thereof |
| 01/12/2010 | US7645903 immunoglobulins; affinity chromatography |
| 01/12/2010 | US7645889 Optically active polymaleimide derivatives and process for their production |
| 01/12/2010 | US7645888 Process for the production of amorphous atorvastatin calcium |
| 01/12/2010 | US7645799 thromboembolic and/or inflammatory disorders; 4-Aminomethyl-cyclohexanecarboxylic acid (1-biphenyl-3-yl-2-phenyl-ethyl)-amide; selective inhibitors of serine protease enzymes of the coagulation cascade and/or contact activation system; improved pharmacological properties, plasma kallikrein activity |
| 01/12/2010 | US7645797 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal |
| 01/12/2010 | US7645760 1-(4-Benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives |
| 01/12/2010 | US7645751 Mandelic acid derivatives and their use as thrombin inhibitors |
| 01/12/2010 | CA2511242C Inhibitors of human tumor-expressed ccxckr2 |
| 01/12/2010 | CA2409664C Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione |
| 01/07/2010 | WO2010001167A2 Novel process |
| 01/07/2010 | WO2010000773A1 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides |
| 01/07/2010 | WO2009118712A3 Novel dihydroxypyrrolidine derivatives as anti-cancer agents |
| 01/07/2010 | WO2008148790A8 Anti -inflammatory substituted cyclobutenedione compounds |
| 01/07/2010 | US20100004464 Method for producing succinimide compound |
| 01/07/2010 | US20100004461 Compounds containing organofluorochlorophosphate anions |
| 01/07/2010 | US20100004428 Method of Preparing Propionic Acid-Terminated Polymers |
| 01/07/2010 | US20100004241 Non-imidazole aryloxyalkylamines |
| 01/07/2010 | US20100003302 Vascular restenosis preventing agent and implantable intravascular device coated therewith |
| 01/07/2010 | US20100003216 HCV NS-3 Serine Protease Inhibitors |
| 01/07/2010 | US20100000302 Process for preparing forms of atorvastatin calcium substantially free of impurities |
| 01/07/2010 | CA2729724A1 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides |
| 01/07/2010 | CA2729253A1 Novel process |
| 01/07/2010 | CA2727739A1 Lubricating oil additive and lubricating oil composition containing same |
| 01/07/2010 | CA2726999A1 New drugs for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases |
| 01/06/2010 | EP2139854A2 P1-nonepimerizable ketoamide inhibitors of hcv ns3 protease |
| 01/06/2010 | EP2139853A1 Process for preparing precursors of carbenes of caac type and use thereof for preparing said carbenes |
| 01/06/2010 | EP2139851A2 Substituted amide derivatives |
| 01/06/2010 | EP2139522A2 Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers |
| 01/06/2010 | EP1735278B1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 01/06/2010 | CN101622229A Novel pyrrole derivative having ureido group and aminocarbonyl group as substituents |
| 01/06/2010 | CN101622228A Method for producing (meth)acrylic esters of n-hydroxyalkylated lactams |
| 01/06/2010 | CN100577741C Reagent for detecting analyte |
| 01/06/2010 | CN100577642C Aluminium and copper metallized insulated material |
| 01/05/2010 | US7642358 Antidiabetic agents; modulate insulin drug resistance |
| 01/05/2010 | US7642323 Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation |
| 01/05/2010 | US7642229 Synergistic antineoplastic effect; side effect reduction |
| 01/05/2010 | US7641702 O-Aminophenol derivatives and colorants containing said compounds |
| 01/05/2010 | CA2545999C 1,2-di(cyclic)substituted benzene compounds |
| 01/05/2010 | CA2318192C .beta.2-adrenergic receptor agonists |